Gan Zhao
Corporate Officer/Principal at Beijing Advaccine Biotechnology Co., Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Qing Ling Yu | F | 58 |
Beijing Advaccine Biotechnology Co., Ltd.
 Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 15 years |
| Bin Wang | M | 66 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 15 years |
| Jian Qun Peng | F | 39 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 4 years |
| Xiao Yan Liu | M | 40 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 4 years |
| Wen Wei Tu | M | 57 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 3 years |
| Lu Nan Zhang | F | 36 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 7 years |
| Guo Hao Jin | M | 35 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 3 years |
| Guan Chun Dai | M | 47 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 3 years |
| Wai Ching Au | F | - |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | - |
| De Cheng Wang | M | 59 |
China Agricultural University
| 16 years |
| Zhi Yun Yu | M | 45 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 4 years |
| Ji Ma | M | 62 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | - |
| Zhou Lu | F | 52 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 12 years |
| Ai Hua Dong | F | 57 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 9 years |
| Dan Liu | M | 50 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 4 years |
| Hong Qin | F | 57 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 3 years |
| Xue Qin Wu | F | 51 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 4 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Chun Hua Lai | F | 42 |
China Agricultural University
| 7 years |
| Shu Bao Sun | M | 61 |
China Agricultural University
| 4 years |
| Cheng Chen | M | 38 |
China Agricultural University
| 4 years |
| Ying Ping Luo | M | 50 |
China Agricultural University
| 1 years |
| Dezhu Li | M | 46 |
China Agricultural University
| 4 years |
| Lin Shu Jiang | M | 53 |
China Agricultural University
| 2 years |
| Jing Wan | F | 35 |
China Agricultural University
| 4 years |
| Feng He | F | 44 |
China Agricultural University
| 1 years |
| Su Jun Shi | F | 46 |
China Agricultural University
| 4 years |
| Darren Li | M | - |
China Agricultural University
| 4 years |
| Xi Liu | M | 40 |
China Agricultural University
| 4 years |
| Ping Liu | F | 49 |
China Agricultural University
| 4 years |
| Bang Cheng Zhang | M | 53 |
China Agricultural University
| 1 years |
| Xiao Ling Li | F | 62 |
China Agricultural University
| 4 years |
| Nan Meng | F | 37 |
China Agricultural University
| 4 years |
| Ping Tao Luo | M | 60 |
China Agricultural University
| 3 years |
| Ying Min | F | 39 |
China Agricultural University
| 1 years |
| Xiao Ming Wei | M | 42 |
China Agricultural University
| 1 years |
| Gen Yi Wen | F | 39 |
China Agricultural University
| 4 years |
| Wei Wang | M | 42 |
China Agricultural University
| 3 years |
| Li San Zhao | M | 62 |
China Agricultural University
| 3 years |
| Lang Liu | M | 61 |
China Agricultural University
| 1 years |
| Biao Ma | M | 60 |
China Agricultural University
| 3 years |
| Liang Shi | M | 39 |
China Agricultural University
| 1 years |
| Xianning Li | M | 38 |
China Agricultural University
| 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 42 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gan Zhao
- Personal Network
